• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期经典方治疗早期糖尿病。

Incipient Diabetes Treated with Long-Term Classical Prescription.

机构信息

Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.

Graduate College, Beijing University of Traditional Chinese Medicine, Beijing 100029, China.

出版信息

J Diabetes Res. 2019 Nov 5;2019:3054213. doi: 10.1155/2019/3054213. eCollection 2019.

DOI:10.1155/2019/3054213
PMID:31781663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6875013/
Abstract

BACKGROUND

Diabetes mellitus (DM) belongs to the progressive and irreversible disease. With the development of the disease, the function of beta cells declines significantly. Current treatments cannot reverse the course of the disease. The role of traditional Chinese medicine (TCM) in the DM treatment has been recognized widely, while there are few long-term observation reports. In this study, we introduced a case of DM treated by classical prescription alone for 10 years, which would provide the reference for clinical practice.

CASE PRESENTATION

A 64-year-old male complained of a 2-month history of dry mouth, frequent urination, and blurred vision and found increased blood glucose for 3 days. The patient's glycated hemoglobin was 14.2%, fasting plasma glucose fluctuated at 12-15 mmol/L, and urinary albumin excretion rate (UAER) was 32.9 g/min. The male was treated with 10 years of continuous classical prescription alone. After 3 months of TCM treatment, the patient's blood glucose level decreased significantly and blurred vision symptoms improved. With continued TCM treatment, his UAER normalized. Subsequently, he continued outpatient consultation, and his TCM prescription was adjusted according to clinical symptoms. After 10 years of continuous TCM treatment, his blood glucose remained stable, urinary microalbumin quantitation showed no abnormalities, and blurred vision disappeared.

CONCLUSIONS

This case provides specific treatment plans and effective references for long-term control of blood glucose, prevention and treatment of diabetes complications, delay of disease progression, and protection of impaired islet function in the treatment of diabetes with TCM. TCM may become a meaningful alternative DM treatment in the future.

摘要

背景

糖尿病(DM)属于进展性和不可逆性疾病。随着疾病的发展,β细胞功能显著下降。目前的治疗方法无法逆转疾病进程。中医药(TCM)在 DM 治疗中的作用已得到广泛认可,但长期观察报告较少。本研究介绍了 1 例单独使用经典方剂治疗 10 年的 DM 病例,为临床实践提供参考。

病例介绍

一名 64 岁男性因口干、尿频和视力模糊 2 个月就诊,发现血糖升高 3 天。患者糖化血红蛋白为 14.2%,空腹血糖波动在 12-15mmol/L 之间,尿白蛋白排泄率(UAER)为 32.9μg/min。该男性接受了 10 年连续单独经典方剂治疗。TCM 治疗 3 个月后,患者血糖水平显著下降,视力模糊症状改善。继续 TCM 治疗后,UAER 恢复正常。随后,他继续门诊就诊,根据临床症状调整 TCM 处方。经过 10 年连续 TCM 治疗,他的血糖保持稳定,尿微量白蛋白定量无异常,视力模糊消失。

结论

本病例为长期控制血糖、预防和治疗糖尿病并发症、延缓疾病进展、保护受损胰岛功能的 TCM 治疗糖尿病提供了具体的治疗方案和有效参考。TCM 可能成为未来有意义的 DM 治疗替代方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa9/6875013/949469967c72/JDR2019-3054213.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa9/6875013/949469967c72/JDR2019-3054213.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa9/6875013/949469967c72/JDR2019-3054213.001.jpg

相似文献

1
Incipient Diabetes Treated with Long-Term Classical Prescription.长期经典方治疗早期糖尿病。
J Diabetes Res. 2019 Nov 5;2019:3054213. doi: 10.1155/2019/3054213. eCollection 2019.
2
Employing observational method for prospective data collection: A case study for analyzing diagnostic process and evaluating efficacy of TCM treatments for diabetes mellitus.采用观察法进行前瞻性数据收集:一项分析糖尿病中医诊疗过程及评估疗效的案例研究。
J Ethnopharmacol. 2016 Nov 4;192:516-523. doi: 10.1016/j.jep.2016.09.015. Epub 2016 Sep 8.
3
Effect of Danzhijiangtang capsule on monocyte chemoattractant protein-1 mRNA expression in newly diagnosed diabetes subclinical vascular lesions.丹蛭降糖胶囊对新诊断糖尿病亚临床血管病变患者单核细胞趋化蛋白-1 mRNA 表达的影响。
World J Gastroenterol. 2013 May 21;19(19):2963-8. doi: 10.3748/wjg.v19.i19.2963.
4
The Effectiveness of Traditional Chinese Medicine Jinlida Granules on Glycemic Variability in Newly Diagnosed Type 2 Diabetes: A Double-Blinded, Randomized Trial.中药金芪降糖颗粒对新诊断 2 型糖尿病患者血糖变异性的影响:一项双盲、随机试验。
J Diabetes Res. 2021 Oct 8;2021:6303063. doi: 10.1155/2021/6303063. eCollection 2021.
5
Diabetes: glycated hemoglobin is a marker of diabetes and CVD risk.糖尿病:糖化血红蛋白是糖尿病和心血管疾病风险的标志物。
Nat Rev Cardiol. 2010 Jul;7(7):367-8. doi: 10.1038/nrcardio.2010.84.
6
Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.吡格列酮可降低葡萄糖耐量受损和糖尿病患者的冠状动脉炎症:FDG-PET/CT 成像评估。
JACC Cardiovasc Imaging. 2013 Nov;6(11):1172-82. doi: 10.1016/j.jcmg.2013.09.004.
7
Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.阿卡波糖与格列本脲对二甲双胍控制不佳的 2 型糖尿病患者血糖波动及氧化应激的影响:一项 24 周、随机、开放、平行分组比较研究。
Clin Ther. 2011 Dec;33(12):1932-42. doi: 10.1016/j.clinthera.2011.10.014. Epub 2011 Nov 10.
8
Effect of Dapagliflozin on Glycemic Variability in Patients with Type 2 Diabetes under Insulin Glargine Combined with Other Oral Hypoglycemic Drugs.达格列净对甘精胰岛素联合其他口服降糖药治疗的 2 型糖尿病患者血糖变异性的影响。
J Diabetes Res. 2020 Nov 24;2020:6666403. doi: 10.1155/2020/6666403. eCollection 2020.
9
Essential factors of Sui Zheng Shi Liang strategy in type 2 diabetes treatment assessed by questionnaire.问卷评估 Sui Zheng Shi Liang 策略在 2 型糖尿病治疗中的重要因素。
J Tradit Chin Med. 2013 Feb;33(1):27-33. doi: 10.1016/s0254-6272(13)60096-5.
10
Acupuncture paired with herbal medicine for prediabetes: study protocol for a randomized controlled trial.针刺联合中药治疗糖尿病前期:一项随机对照试验的研究方案
Trials. 2017 Jun 28;18(1):297. doi: 10.1186/s13063-017-2014-4.

引用本文的文献

1
Hypoglycemic Effect of an Herbal Decoction (Modified Gangsimtang) in a Patient with Severe Type 2 Diabetes Mellitus Refusing Oral Anti-Diabetic Medication: A Case Report.中药复方(降糖散改良方)治疗拒绝口服降糖药的严重 2 型糖尿病患者的低血糖作用:病例报告。
Medicina (Kaunas). 2023 Oct 30;59(11):1919. doi: 10.3390/medicina59111919.

本文引用的文献

1
Combined systems pharmacology and fecal metabonomics to study the biomarkers and therapeutic mechanism of type 2 diabetic nephropathy treated with and Leech.联合系统药理学和粪便代谢组学研究水蛭治疗2型糖尿病肾病的生物标志物及治疗机制
RSC Adv. 2018 Aug 1;8(48):27448-27463. doi: 10.1039/c8ra04358b. eCollection 2018 Jul 30.
2
Evidence and potential mechanisms of traditional Chinese medicine for the treatment of type 2 diabetes: A systematic review and meta-analysis.中医药治疗 2 型糖尿病的证据和潜在机制:系统评价和荟萃分析。
Diabetes Obes Metab. 2019 Aug;21(8):1801-1816. doi: 10.1111/dom.13760. Epub 2019 Jun 17.
3
Efficacy of different antidiabetic drugs based on metformin in the treatment of type 2 diabetes mellitus: A network meta-analysis involving eight eligible randomized-controlled trials.
基于二甲双胍的不同降糖药物治疗 2 型糖尿病的疗效:一项纳入八项合格随机对照试验的网络荟萃分析。
J Cell Physiol. 2019 Mar;234(3):2795-2806. doi: 10.1002/jcp.27097. Epub 2018 Aug 26.
4
Safety and Tolerability of Combinations of Empagliflozin and Linagliptin in Patients with Type 2 Diabetes: Pooled Data from Two Randomized Controlled Trials.恩格列净和利拉利汀联合治疗 2 型糖尿病患者的安全性和耐受性:两项随机对照试验的汇总数据。
Adv Ther. 2018 Jul;35(7):1009-1022. doi: 10.1007/s12325-018-0724-y. Epub 2018 Jun 15.
5
The Efficacy and Safety of the Chinese Herbal Formula, JTTZ, for the Treatment of Type 2 Diabetes with Obesity and Hyperlipidemia: A Multicenter Randomized, Positive-Controlled, Open-Label Clinical Trial.中药方剂JTTZ治疗2型糖尿病伴肥胖和高脂血症的疗效与安全性:一项多中心随机、阳性对照、开放标签临床试验
Int J Endocrinol. 2018 Apr 1;2018:9519231. doi: 10.1155/2018/9519231. eCollection 2018.
6
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.国际糖尿病联盟(IDF)糖尿病地图集:2017 年全球糖尿病患病率估计数和 2045 年预测值。
Diabetes Res Clin Pract. 2018 Apr;138:271-281. doi: 10.1016/j.diabres.2018.02.023. Epub 2018 Feb 26.
7
Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013.2013年中国糖尿病及糖尿病前期的患病率与民族分布特征
JAMA. 2017 Jun 27;317(24):2515-2523. doi: 10.1001/jama.2017.7596.
8
Evaluation of the Chinese herbal medicine Jinlida in type 2 diabetes patients based on stratification: Results of subgroup analysis from a 12-week trial.基于分层的 2 型糖尿病患者中药金力达的评估:来自 12 周试验的亚组分析结果。
J Diabetes. 2018 Feb;10(2):112-120. doi: 10.1111/1753-0407.12559. Epub 2017 Jun 5.
9
Synergistic Effects of Danshen (Salvia Miltiorrhiza Radix et Rhizoma) and Sanqi (Notoginseng Radix et Rhizoma) Combination in Inhibiting Inflammation Mediators in RAW264.7 Cells.丹参和三七联合对RAW264.7细胞炎症介质的抑制作用
Biomed Res Int. 2016;2016:5758195. doi: 10.1155/2016/5758195. Epub 2016 Oct 18.
10
The Role of the Vagal Nucleus Tractus Solitarius in the Therapeutic Effects of Obesity Surgery and Other Interventional Therapies on Type 2 Diabetes.孤束核迷走神经核在肥胖手术及其他介入治疗对2型糖尿病的治疗作用中的角色。
Obes Surg. 2016 Dec;26(12):3045-3057. doi: 10.1007/s11695-016-2419-2.